SV

Srilatha Vuppala

Active Director Director DIN 10621088
DIN 10621088 First appointment May 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Srilatha Vuppala

Data last updated:

Srilatha Vuppala is a Director at Cenmed Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10621088
Primary Designation Director
Industry Pharma
First Appointment 08 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 May 20242024Active

Board colleagues of Srilatha Vuppala

NameDINCompanyDesignation
Sreenivas Vuppala10621087Cenmed Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cenmed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Srilatha Vuppala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srilatha Vuppala

Srilatha Vuppala currently holds 1 directorship: Cenmed Pharmaceuticals Private Limited (Director, since 08 May 2024).

Srilatha Vuppala was first appointed on 08 May 2024 as Director at Cenmed Pharmaceuticals Private Limited.

The current boards of Srilatha Vuppala's companies include Sreenivas Vuppala (Cenmed Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available